hydromethylthionine has been researched along with DDPAC in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Baddeley, TC; Bentham, P; Bracoud, L; Ganesan, H; Gauthier, S; Hammel, J; Hardlund, J; Harrington, CR; Jia, J; Kipps, CM; Kook, K; Moebius, HJ; Murray, AD; Riedel, G; Rubino, CM; Schelter, BO; Shiells, H; Staff, RT; Storey, JMD; Vuksanovic, V; Wischik, CM; Wischik, DJ | 1 |
Bentham, P; Harrington, CR; Schelter, BO; Shiells, H; Staff, RT; Wischik, CM | 1 |
Harrington, CR; Magbagbeolu, M; Melis, V; Riedel, G; Schwab, K; Theuring, F; Wischik, CM | 1 |
1 trial(s) available for hydromethylthionine and DDPAC
Article | Year |
---|---|
Concentration-Dependent Activity of Hydromethylthionine on Clinical Decline and Brain Atrophy in a Randomized Controlled Trial in Behavioral Variant Frontotemporal Dementia.
Topics: Adult; Aged; Atrophy; Brain; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Frontotemporal Dementia; Humans; Magnetic Resonance Imaging; Male; Methylene Blue; Middle Aged; Treatment Outcome | 2020 |
2 other study(ies) available for hydromethylthionine and DDPAC
Article | Year |
---|---|
Long-Term Hydromethylthionine Treatment Is Associated with Delayed Clinical Onset and Slowing of Cerebral Atrophy in a Pre-Symptomatic P301S MAPT Mutation Carrier.
Topics: Adult; Atrophy; Brain; Carrier State; Frontotemporal Dementia; Humans; Magnetic Resonance Imaging; Male; Methylene Blue; Mutation; tau Proteins; Time Factors | 2021 |
Proteomic Analysis of Hydromethylthionine in the Line 66 Model of Frontotemporal Dementia Demonstrates Actions on Tau-Dependent and Tau-Independent Networks.
Topics: Animals; Female; Frontotemporal Dementia; Immunohistochemistry; Methylene Blue; Mice; Mice, Transgenic; Proteomics; Tandem Mass Spectrometry; tau Proteins | 2021 |